State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2018-2022

All Races (includes Hispanic), Female, All Ages

Sorted by Percentlate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 3.1 to 3.1 and 6,720 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

District of Columbia²

• Rate : The incidence rate is 1.6 with a 95% confidence interval from 1.1 to 2.3 and 6 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (45, 51)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.8 to 3.6 and 63 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (7, 44)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.1 and 97 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (20, 49)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 1.2 with a 95% confidence interval from 1.0 to 1.4 and 31 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.1 to 3.9 and 68 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (1, 33)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.3 to 2.7 and 137 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (39, 51)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.5 and 147 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (10, 36)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.6 to 3.2 and 105 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (19, 48)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.4 to 3.9 and 14 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (1, 50)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 215 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (17, 41)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 3.0 and 110 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (24, 50)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.0 to 3.5 and 11 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (4, 51)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.4 to 3.1 and 42 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (19, 50)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.3 to 3.8 and 146 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (3, 24)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.5 to 3.8 and 18 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (1, 50)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.1 to 2.7 and 46 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (34, 51)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.4 to 3.6 and 21 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (4, 50)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.6 to 4.3 and 119 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 15)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.6 to 4.3 and 99 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 16)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.3 to 2.8 and 88 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (28, 50)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.2 to 3.2 and 27 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (14, 51)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.4 to 4.0 and 112 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (1, 22)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.6 to 2.9 and 455 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (30, 48)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.4 to 4.5 and 52 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 23)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.7 to 4.0 and 618 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (1, 12)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.1 to 4.1 and 43 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (1, 39)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.1 to 3.9 and 64 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (1, 35)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.5 and 214 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (9, 31)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 134 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (23, 48)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.7 to 2.9 and 382 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (27, 47)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.8 and 155 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (3, 24)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.1 and 206 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (21, 45)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.5 and 130 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (9, 38)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.7 to 3.0 and 264 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (25, 47)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.5 to 3.5 and 32 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (8, 50)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.6 and 277 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (6, 24)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.4 to 3.0 and 69 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (23, 50)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.8 to 3.0 and 693 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (25, 43)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.7 to 3.7 and 37 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (3, 48)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.6 to 3.2 and 84 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (16, 48)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.8 to 3.2 and 142 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (17, 45)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.7 and 290 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (6, 24)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.1 and 181 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (22, 47)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.5 to 4.3 and 84 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (1, 19)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 2.5 to 4.2 and 15 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (1, 50)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.7 to 3.2 and 140 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (19, 46)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.2 to 3.7 and 128 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (4, 27)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 2.7 to 4.0 and 25 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (1, 49)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.2 to 4.1 and 51 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (1, 34)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.1 to 3.0 and 26 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (20, 51)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 2.8 to 4.6 and 15 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (1, 49)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.3 to 4.7 and 30 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 27)
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/21/2026 11:55 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.